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Abstract
The predictive power, for total, vascular, cancer and respiratory mortality, of selected redox-modulatory (vitamin and mineral nutrient)
indices measured at baseline, was studied in the British National Diet and Nutrition Survey (community-living subset) of people aged
65 years and over. Mortality status and its primary and underlying causes were recorded for 1054 (mean age 76·6 (SD 7·4) years and
49·0 % female) participants, from the baseline survey in 1994–5 until September 2008. During this interval, 74 % of the male and 62 %
of the female participants died. Total mortality was significantly predicted by baseline plasma concentrations (per SD) of vitamin C
(hazard ratio (HR) 0·81; 95 % CI 0·74, 0·88), a-carotene (HR 0·90; 95 % CI 0·81, 0·99), Se (HR 0·76; 95 % CI 0·69, 0·84), Zn (HR 0·79;
95 % CI 0·72, 0·87), Cu (HR 1·27; 95 % CI 1·14, 1·42) and Fe (HR 0·81; 95 % CI 0·74, 0·89). Total mortality was also significantly predicted
by baseline dietary intakes (per SD) of food energy (HR 0·86; 95 % CI 0·79, 0·94), vitamin C (HR 0·88; 95 % CI 0·80, 0·94), carotenoids (HR
0·89; 95 % CI 0·83, 0·96), Zn (HR 0·89; 95 % CI 0·82, 0·96) and Cu (HR 0·91; 95 % CI 0·84, 1·00). Prediction patterns and significance for
primary vascular, cancer and respiratory mortality differed in certain respects, but not fundamentally. Model adjustment for known disease
or mortality risk predictors resulted in loss of significance for some of the indices; however, plasma Se and Zn, and food energy remained
significant predictors. We conclude that total and primary vascular, cancer and respiratory mortality in older British people of both sexes is
predicted by several biochemical indices of redox-modulatory nutrients, some of which may reflect the respondents’ acute-phase status
at baseline, whereas others may reflect the healthiness of their lifestyle.
Key words: British National Survey of Older Adults: Mortality prediction: Intakes and biochemical indices: Plasma vitamins C
and E, carotenoids, selenium, zinc, copper and iron
Relationships between biochemical status indices and
later morbidity and mortality experience can help to pre-
dict causal relationships, and thereby to clarify certain
physiological and pathological mechanisms that may be
related to important disease risk factors in ageing
humans. In the present study, we have focused on mor-
tality outcomes of the community-living participants
from the countrywide British National Diet and Nutrition
Survey of people aged 65 years and over, for which the
fieldwork was performed in 1994–5(1). Subsequent mor-
tality outcomes were available from the National Health
Service register of deaths, up to September 2008. The pur-
pose of the present paper is to explore the predictive sig-
nificance of a selection of biochemical indices for
nutrients that are believed to mediate redox-modulatory
(antioxidant or pro-oxidant) functions in living tissues,
all of which were measured as part of the original
population surveillance protocol. Evidence that sub-
sequent all-cause mortality may be predicted by vitamin
C intakes and/or status has been obtained in several
previous studies(2–10), and similarly for carotene(11,12)
and Se(12–14).
In addition to the modulation of redox status, several
nutrient indices are known to be modified by, and hence
to reflect, acute-phase status, and hence, potentially, to
reflect mortality risk (since chronic inflammatory states
frequently underlie those disease processes that lead
ultimately to death(15)). Also, the same vitamins and min-
erals that modulate redox status may, in many cases, also
modulate key immune functions(16–18). As well as the prac-
tical usefulness of status indices as predictors of future
mortality, a key question is whether the observed links
between baseline nutrient status and future mortality are
likely to be driven by (potentially correctable) nutritional
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imbalances, or by the more intractable processes of
inflammatory response to chronic disease?
Subjects and methods
The survey procedures have been described in detail
elsewhere(1); therefore only a brief summary is given
here. At baseline, in 1994–5, two separate population
samples were randomly selected: one from community-
living people aged 65 years and over and the other from
long-stay institutions. Only the community-living sample
has been included in the present study. Participants were
drawn from eighty randomly selected postcode sectors
in mainland Britain and allocated to four sequential
3-month fieldwork ‘waves’ corresponding to the four
seasons, beginning in October 1994. Demographic, socio-
economic and other information was obtained by a trained
interviewer in the participant’s home. A 4 d weighed
dietary record was also obtained by the interviewer, and
anthropometric indices, blood pressure and pulse rate,
and after separate consent, a fasting early morning
venous blood sample were taken by a trained nurse.
The blood sample was subdivided and used for a wide
range of analyses. Of these, the assays that are relevant
to the present study were as follows: (a) fluorometric
assay based on the reaction of dehydroascorbic acid with
ortho-phenylenediamine (checked for validity against
a HPLC assay and against quality assurance standards
with assigned values, provided by the US National Institute
of Standards and Technology) for plasma (total) vitamin C;
(b) liquid chromatographic assay for plasma retinol, a- and
g-tocopherols and carotenoids; (c) colorimetric assays
for plasma Zn, Cu, Fe and Fe% saturation of transferrin;
(d) an antibody-based nephelometric assay for plasma
a1-antichymotrypsin; (e) an inductively coupled plasma
MS assay for plasma Se. In-house quality assessments and
inter-laboratory exchanges were undertaken in order to
monitor the accuracy and stability of the assays. Plasma
a1-antichymotrypsin was selected as a medium-duration
plasma acute-phase indicator, which tends to remain
raised during chronic inflammatory states. Between-run
quality-control sample CV were all # 11 %, and the mean
quality-control CV was 5·7 %.
The study was conducted according to the guidelines
laid down in the Declaration of Helsinki, and all
procedures involving human subjects were approved by
the Local Research Ethics Committees representing each
of the eighty postcode sectors used. The protocol was
also approved by the Ethical Committee of the MRC
Dunn Nutrition Unit (of which the Micronutrient Status
Laboratory is now part of MRC Human Nutrition Research),
in Cambridge. Written informed consent was obtained
from all the subjects.
The present study included 1054 participants, compris-
ing 538 men and 516 women, with partial or complete
data available for the analyses of interest here, all of
whom agreed to be flagged on the National Register
of Births and Deaths, and whose status (i.e. as still alive
or registered as having died) was known in September
2008. No exclusions, other than those resulting from
willingness to participate or the availability of blood
samples, were imposed, and there was no evidence for
sampling bias. Because of missing values (principally due
to incomplete consent availability for the blood sampling),
the analyses of the blood biomarker variables are typically
based on a subset of approximately 800 participants.
Statistical analysis
Cox proportional hazards models were used, with years
of survival as the time scale, to estimate the risk of
mortality (all-cause and vascular disease) according to
each biochemical and nutritional index. The data were
censored to September 2008 in those participants who
had survived. The proportional hazards assumption was
examined by comparing the cumulative hazard plots,
grouped as exposure, wherein no appreciable violations
were observed. We used standardised values (z-scores)
for each of the explanatory variables examined, which
have the advantage of expressing the hazard ratios per
standard deviation, rather than per measurement unit,
thereby achieving an enhanced conformity between the
disparate indices. Vascular disease mortality was defined
according to International Classification of Diseases –
versions 9 (ICD-9: 390-459) and 10 (ICD-10: I01-I99).
Cancer mortality was defined according to ICD-9: 140-239
and ICD-10: C00-D48. Respiratory disease mortality
was defined according to ICD-9: 460-519 and ICD-10:
J00-J99, and all of the above were limited to the primary
cause of death.
In the multivariate models, adjustment was made
for potential confounders, including age and sex in all
models. Since we were only interested in relationships
between indices, rather than estimates of prevalence, we
did not apply the weighting factors that were used in the
data analyses for the Survey Report(1). All tests of statistical
significance were based on two-sided probability, and
P,0·05 was deemed significant throughout.
Results
Of the community-living survey participants who gave
consent for follow-up flagging of the National Health
Service Register of deaths, and who had provided at least
one index value reported in this follow-up study, 94·5 %
could be accounted for by known deaths and known
survivors. As noted previously in the Subjects and methods
section, the blood biomarker analyses are confined to the
subset of the participants who provided a blood sample,
comprising approximately 800 participants.
Table 1 provides mean and median baseline values,
subdivided by sex, for the indices explored in this report.
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The original Survey Report(1) provided baseline index
values for all of the original survey participants, together
with further details about the aims of the selection
procedures and the methodologies used.
Table 2 shows the age- and sex-adjusted hazard ratios
for all-cause and primary vascular disease-cause mortality.
Significant predictors of all-cause mortality were as follows:
plasma vitamin C, a-carotene, lutein þ zeaxanthin, Se, Zn,
Cu, Fe (and the % saturation of its carrier, Fe-binding
protein or transferrin); plasma a1-antichymotrypsin, and
dietary intakes of energy, vitamin C, carotenoids, Zn
and Cu. With the exception of plasma Cu and a1-antichy-
motrypsin, all of the significant mortality predictors
had hazard ratios below 1·0, which signifies reduced risk.
a1-Antichymotrypsin concentrations are known to increase
during inflammatory states, and hence the association of
increased concentrations with increased risk, i.e. hazard
ratios greater than 1·0. The major Cu-containing plasma
protein, caeruloplasmin, like a1-antichymotrypsin, also
increases during inflammatory states, which probably
explains the observed association of increased concen-
trations with increased risk. Serum ferritin (not shown)
was not a significant predictor of mortality, either for all-
cause or for the three subcategories of mortality risk
considered here. Likewise, neither a-tocopherol nor
g-tocopherol became significant predictors, for all-cause,
vascular disease or cancer mortality, even when adjusted
for plasma (total) cholesterol (not shown). Intakes of
food energy, vitamin C, total carotenoids, Zn and Cu
were significant predictors of mortality, with increased
intakes being associated with longer survival for each
of these nutrients (Table 2). If food energy was
included in the model (not shown), then vitamin C and
carotenoid intakes still retained their prediction signifi-
cance (P¼0·003 and 0·046, respectively), whereas the
other nutrient intakes shown in Table 2 lost their signifi-
cance (P.0·05).
When subdivided by sex (not shown), the predictive
power of the biochemical status indices was similar for
both men and women, with the exception of plasma Cu,
which was significant only for men (hazard ratio 1·60
(95 % CI 1·35, 1·90) (P#0·001)) compared with women
(hazard ratio 1·06 (95 % CI 0·93, 1·22) (P¼0·4)). The predic-
tive power of nutrient intakes was significant (P,0·05)
Table 1. Summary of selected status indices and nutrient intakes in the survey respondents who are included in the present study (n 1054)
(Mean values and standard deviations; median and range values)
Male Female
n* Mean SD Median Range n* Mean SD Median Range
Age (years) 538 75·8 6·9 75·0 65–96 516 77·3 7·9 76·0 65–99
Body wt (kg) 532 75·2 12·2 74·6 38·7–121 509 64·0 12·7 63·3 32·5–112·9
Ht (m) 528 1·69 0·07 1·69 1·49–1·98 503 1·55 0·07 1·55 1·20–1·75
BMI (kg/m2) 527 26·3 3·7 26·1 16·3–43·2 502 26·6 4·8 26·2 14·4–44·6
Biochemical indices
Plasma vitamin C (mmol/l) 442 38·2 22·6 38·6 ,3–101·5 410 45·8 26·1 48·2 ,3–116·5
Plasma vitamin A (mmol/l) 409 2·21 0·58 2·15 0·85–5·55 390 2·18 0·66 2·09 0·42–6·8
Plasma a-tocopherol (mmol/l) 409 35·0 9·9 34·2 0·45–7·49 390 39·1 12·4 37·5 10·3–128·0
Plasma g-tocopherol (mmol/l) 407 2·24 1·06 2·07 0·45–7·49 385 2·53 1·20 2·31 0·57–8·65
Plasma a-carotene (nmol/l) 403 64·0 64·0 51·0 5·0–84·8 385 79·5 84·4 55·0 4·0–88·8
Plasma b-carotene (nmol/l) 408 323 225 273 8–1674 390 405 261 349 37–1960
Plasma b-cryptoxanthin (nmol/l) 399 117 121 77 3–866 389 151 165 98 4–1265
Plasma lutein þ zeaxanthin (nmol/l) 409 378 179 340 99–1583 390 389 212 352 66–2189
Plasma lycopene (nmol/l) 408 268 184 238 12–1015 389 274 209 225 8–1262
Plasma Se (mmol/l) 428 95 218 962 375–2376 398 924 211 925 461–1786
Blood glutathione peroxidase
(nmol NADPH/mg Hb per min)
412 140 34 133 59–359 369 145 37 13 85–353
Plasma Zn (mmol/l) 377 14·2 2·1 14·1 7·2–20·5 364 14·2 2·4 14·0 8·2–24·2
Plasma Cu (mmol/l) 376 17·4 3·0 17·0 10·4–31·5 362 19·5 3·9 19·3 8·4–38·0
Plasma Fe (mmol/l) 438 13·7 4·9 13·0 2·8–37·4 412 12·0 4·4 11·9 2·2–32·3
Plasma Fe % saturation (%) 437 28·1 11·1 26·7 4·1–91·2 412 24·2 10·3 23·5 4·0–82·7
Plasma a1-antichymotrypsin (g/l) 430 0·38 0·094 0·365 0·16–1·14 408 0·39 0·089 0·385 0·22–1·01
Estimated average daily dietary intakes
Energy (MJ) 538 7·95 1·94 7·95 3·44–17·3 516 5·95 1·42 5·88 1·91–9·77
Vitamin C (mg) 538 71·1 70·5 59·0 4·9–1023 516 65·4 57·1 49·0 1·0–601
Vitamin A (retinol) (mg) 538 0·94 1·76 0·45 ,0·01–20·4 516 0·85 1·56 0·39 0·06–18·8
Vitamin E (mg) 538 9·51 8·18 7·80 0·8–114 516 10·69 39·4 6·09 0·06–18·8
Total carotenoids (mg) 538 1·97 1·55 1·62 0·10–12·0 516 1·62 1·40 1·12 0·06–9·97
Zn (mg) 538 8·81 2·86 8·50 1·86–27·1 516 6·96 2·56 6·52 1·65–23·3
Cu (mg) 538 1·10 0·68 0·97 0·29–6·72 516 0·88 0·55 0·77 0·19–5·87
Non-haem Fe (mg) 538 11·4 10·3 10·0 1·7–174·2 516 10·9 18·4 7·9 2·3–201·5
Haem Fe (mg) 538 0·72 0·57 0·59 0·00–4·83 516 0·53 0·45 0·42 0·00–4·80
* The values for n in Table 1 and the maximum values for n in Tables 2 and 3 are limited to the numbers definitely known to have died or to have been still alive at the time of
the follow-up analysis, i.e. they excluded those (approximately 5 % of the original participants) who were lost to follow-up. Where individual index values of n are lower in
Tables 2 and 3, it was because of missing values, since not all of the respondents provided blood (or sufficient blood) for every one of the assays or calculations(1).
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for men for food energy, vitamins C and E, carotenoids,
Zn and Cu, but was NS for women, for any of these nutri-
ent intakes. After adjustment for food energy, intakes of
vitamin C and carotenoids remained significant for men
(P¼0·03 for both).
For primary vascular disease mortality, comprising
approximately 26 % of all mortality, the significant predic-
tors were similar to those for all-cause mortality; however,
plasma a-carotene, lutein þ zeaxanthin and dietary
energy, and intakes of carotenoids and Cu failed to achieve
significance at the 5 % probability level here.
For primary cancer mortality, comprising approximately
20 % of all mortality, the significant biochemical index
predictors were similar to those for all-cause mortality, with
the exceptions that plasma lutein þ zeaxanthin, Cu and a1-
antichymotrypsin were NS. Here, the only dietary intakes
that were significant were those of vitamins C and E.
For primary respiratory disease mortality, comprising
approximately 16 % of all mortality, the significant bio-
chemical index predictors were similar to those for all-
cause mortality, with the exception that plasma a-carotene,
Cu, Fe and a1-antichymotrypsin were NS, but lycopene
became marginally significant. The only dietary intake to
achieve significance here was that of total carotenoids.
When subdivided both by sex and by primary cause of
mortality (not shown), the most striking sex differences
again arose with respect to plasma Cu, which was a
significant predictor of primary vascular disease or cancer
or respiratory disease mortality, for males only, but not
for females. Dietary intake of vitamin E was a significant
predictor of cancer and respiratory disease mortality in
males but not in females, and dietary intake of carotenoids
was a significant predictor of respiratory disease mortality
in males but not in females. However, in contrast to pre-
vious studies which have described significant mortality
prediction by low serum or plasma vitamin C concen-
trations in men but not in women(2,6–8), the present
study found similar strengths of mortality prediction by
plasma vitamin C in both men and women.
About 19 % of the study respondents were regularly
taking dietary supplements that contained vitamin and/or
mineral components, at baseline. However, subsequent
mortality was not significantly predicted by the supplemen-
tal intakes of any of the above-mentioned vitamins or
minerals, and the mortality prediction patterns were similar
in the (81 %) non-supplement users, to those of the entire
cohort (not shown).
Exclusion of those respondents (approximately 7 %)
who died in less than 2 years after the baseline field-
work made little difference to any of the index predictions
of mortality (not shown); therefore the observed
patterns of mortality prediction appear not to have been
Table 2. Age- and sex-adjusted risk for the biochemical and nutritional indices, for all-cause and primary vascular disease mortality*
(Hazard ratios and 95 % confidence intervals)
All-cause mortality: died n 717, alive n 337 Vascular disease mortality: died n 189, alive n 337*
Age- and sex-adjusted
hazard ratios 95 % CI P
Age- and sex-adjusted
hazard ratios 95 % CI P
Biochemical indices (per SD)
Plasma vitamin C (mmol/l) 0·81 0·74, 0·88 ,0·001 0·83 0·71, 0·98 0·02
Plasma vitamin A (mmol/l) 0·96 0·87, 1·06 0·4 1·01 0·84, 1·21 0·9
Plasma a-tocopherol (mmol/l) 0·96 0·87, 1·06 0·4 1·07 0·90, 1·29 0·4
Plasma g-tocopherol (mmol/l) 0·96 0·87, 1·05 0·3 0·91 0·75, 1·11 0·4
Plasma a-carotene (nmol/l) 0·90 0·81, 0·99 0·04 1·01 0·85, 1·20 0·9
Plasma b-carotene (nmol/l) 0·92 0·84, 1·01 0·08 0·96 0·81, 1·15 0·7
Plasma b-cryptoxanthin (nmol/l) 0·91 0·83, 1·01 0·07 1·04 0·86, 1·26 0·7
Plasma lutein þ zeaxanthin (nmol/l) 0·91 0·83, 1·00 0·04 0·90 0·75, 1·08 0·3
Plasma lycopene (nmol/l) 0·92 0·84, 1·01 0·09 0·86 0·71, 1·05 0·15
Plasma Se (mmol/l) 0·76 0·69, 0·84 ,0·001 0·73 0·61, 0·87 0·001
Blood glutathione peroxidase
(nmol NADPH/mg Hb per min)
0·94 0·85, 1·03 0·2 1·00 0·84, 1·20 1·0
Plasma Zn (mmol/l) 0·79 0·72, 0·87 ,0·001 0·73 0·61, 0·88 0·001
Plasma Cu (mmol/l) 1·27 1·14, 1·42 ,0·001 1·35 1·12, 1·63 0·002
Plasma Fe (mmol/l) 0·81 0·74, 0·89 ,0·001 0·79 0·67, 0·94 0·008
Plasma Fe % saturation (%) 0·84 0·76, 0·92 ,0·001 0·79 0·67, 0·94 0·009
Plasma a1-antichymotrypsin (g/l) 1·22 1·14, 1·32 ,0·001 1·12 1·05, 1·35 0·005
Daily dietary intakes (per SD)
Energy (MJ) 0·86 0·79, 0·94 0·001 0·83 0·70, 1·00 0·05
Vitamin C (mg) 0·88 0·80, 0·97 0·008 0·93 0·81, 1·08 0·4
Vitamin A (mg) 1·00 0·93, 1·07 1·0 0·95 0·82, 1·10 0·5
Vitamin E (mg) 1·00 0·93, 1·08 0·9 1·06 0·90, 1·23 0·5
Total carotenoids (mg) 0·89 0·82, 0·96 0·003 0·95 0·83, 1·10 0·5
Zn (mg) 0·89 0·82, 0·96 0·003 0·84 0·71, 0·99 0·04
Cu (mg) 0·91 0·84, 1·00 0·04 0·92 0·78, 1·10 0·4
Non-haem Fe (mg) 1·03 0·94, 1·13 0·5 1·06 0·94, 1·20 0·4
Haem Fe (mg) 1·03 0·97, 1·10 0·3 0·93 0·82, 1·07 0·3
* As explained in the legend to Table 1, these were the study maximum values for n; the actual values for each index were the same as shown in Table 1.
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disproportionately affected by early deaths, and hence by
the effects of serious illness on appetite or status indices
at baseline.
Tables 4–7 show which of the nutrient indices survive
into multivariate models: part (a) in each table contains
just age, sex, and each single status and dietary indices
that were found to be significant as shown in Tables 2
and 3; part (b) contains all of the significantly predictive
nutrient variables plus age and sex, followed by removal
of those which then became non-significant in the multi-
variate model; part (c) contains these same indices, plus
five further ‘risk’ indices that were measured at baseline,
namely: a1-antichymotrypsin (acute-phase status indi-
cator), plasma creatinine (renal status indicator), plasma
total and HDL-cholesterol concentrations (traditional
vascular disease risk indicators), plasma albumin concen-
tration (frailty indicator); and finally part (d) also contains
BMI, systolic blood pressure, current smoking index,
number of prescribed drugs being taken, self-reported
health score, physical activity score and receipt (or not)
of certain state benefits (a potential index of relative pov-
erty). For all-cause mortality (Table 4), only the mineral
status indices (for Se, Zn, Cu and Fe) plus dietary energy
remained significant in the partly adjusted multivariate
model (b), with only plasma Se, Zn and dietary energy
surviving to the fully adjusted model (d). In Tables 5
and 6, somewhat similar patterns were observed for
primary vascular and primary cancer mortality; however,
for the latter (alone), haem Fe was a significant predictor,
and indeed, became progressively more significant in the
more fully adjusted multivariate models. Dietary vitamin
E (but not dietary energy) was significant for cancer mor-
tality. From Table 7, it can be observed that only plasma
a-tocopherol and dietary carotenoids were significant
predictors for respiratory disease mortality. It can be
observed from Tables 4–7 that for some of the nutritional
variables and mortality types, there was a steady pro-
gression towards decreasing significance of mortality
prediction in the more fully adjusted models, whereas for
other nutritional variables and mortality types, the predic-
tion significance either stayed essentially the same or
even increased in the more fully adjusted models.
Discussion
Because the predictive value of conventional risk factors
for disease and mortality appears to diminish with advan-
cing age(19), recent attention has focused on the discrimina-
tive ability of novel risk markers in elderly cohorts(20). The
purpose of the present paper is to explore the predictive
significance of a subset of the biochemical status indices
and nutrient intakes that were measured at baseline as
Table 3. Age- and sex-adjusted risk for the biochemical and nutritional indices for primary cancer and primary respiratory disease mortality*
(Hazard ratios and 95 % confidence intervals)
Cancer mortality: died n 140, alive n 337 Respiratory disease mortality: died n 112, alive n 337*
Age- and sex-adjusted
hazard ratios 95 % CI P
Age- and sex-adjusted
hazard ratios 95 % CI P
Biochemical indices (per SD)
Plasma vitamin C (mmol/l) 0·81 0·66, 0·99 0·035 0·78 0·63, 0·96 0·02
Plasma vitamin A (mmol/l) 0·90 0·73, 1·12 0·4 0·88 0·70, 1·11 0·3
Plasma a-tocopherol (mmol/l) 0·96 0·87, 1·06 0·4 0·76 0·60, 0·96 0·02
Plasma g-tocopherol (mmol/l) 0·89 0·71, 1·13 0·3 0·84 0·65, 1·08 0·2
Plasma a-carotene (nmol/l) 0·67 0·47, 0·96 0·03 0·94 0·75, 1·18 0·6
Plasma b-carotene (nmol/l) 0·87 0·69, 1·10 0·25 0·84 0·67, 1·05 0·13
Plasma b-cryptoxanthin (nmol/l) 0·86 0·66, 1·13 0·3 0·80 0·58, 1·09 0·16
Plasma luteinþzeaxanthin (nmol/l) 1·06 0·87, 1·30 0·5 0·77 0·60, 0·99 0·04
Plasma lycopene (nmol/l) 1·06 0·87, 1·30 0·5 0·77 0·59, 1·00 0·05
Plasma Se (mmol/l) 0·72 0·58, 0·89 0·002 0·65 0·51, 0·82 ,0·001
Blood glutathione peroxidase
(nmol NADPH/mg Hb per min)
1·00 0·81, 1·23 1·0 0·83 0·65, 1·05 0·12
Plasma Zn (mmol/l) 0·69 0·55, 0·86 0·001 0·79 0·62, 0·99 0·04
Plasma Cu (mmol/l) 1·18 0·92, 1·49 0·2 1·12 0·89, 1·41 0·3
Plasma Fe (mmol/l) 0·73 0·59, 0·89 0·002 0·83 0·66, 1·04 0·11
Plasma Fe % saturation (%) 0·72 0·58, 0·89 0·002 0·93 0·74, 1·16 0·5
Plasma a1-antichymotrypsin (g/l) 1·08 0·91, 1·27 0·4 1·15 0·98, 1·36 0·09
Daily dietary intakes (per SD)
Energy (kJ) 0·82 0·67, 1·01 0·06 0·85 0·66, 1·08 0·2
Vitamin C (mg) 0·73 0·57, 0·94 0·015 0·81 0·62, 1·05 0·11
Vitamin A (mg) 1·03 0·88, 1·019 0·7 0·87 0·70, 1·09 0·2
Vitamin E (mg) 0·13 0·04, 0·42 0·001 0·32 0·10, 1·08 0·07
Total carotenoids (mg) 0·92 0·77, 1·10 0·3 0·74 0·59, 0·93 0·01
Zn (mg) 0·86 0·71, 1·04 0·11 0·88 0·70, 1·09 0·2
Cu (mg) 0·87 0·71, 1·04 0·2 0·96 0·78, 1·18 0·7
Non-haem Fe (mg) 1·05 0·93, 1·18 0·4 0·97 0·79, 1·27 1·0
Haem Fe (mg) 1·18 1·03, 1·35 0·014 0·96 0·80, 1·15 0·7
* As explained in the legend to Table 1, these were the study maximum values for n; the actual values for each index were the same as shown in Table 1.
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part of the original population surveillance protocol of
the National Diet and Nutrition Survey of People Aged
65 Years and Over, with a specific focus on those nutrients
that are known to modulate redox status in living tissues.
Important strengths of the present study are that, as
far as possible, the population sample was chosen as
being statistically representative of the community-living
people of mainland Britain in 1994–5. A wide range of
nutrition-related factors was measured at baseline, includ-
ing questionnaire-derived socio-demographic information,
a 4 d weighed diet estimate, anthropometric measure-
ments, haematology, blood and urine biochemistry
(including a large number of nutritional indices), dental
assessment, etc., and the follow-up period for mortality
outcomes was substantial, i.e. 13–14 years. One inevitable
weakness, invariably associated with any cross-sectional
national survey, was the fact that the baseline measures
were sampled at a single time-point only. It was thus, in
principle, unable to address the issues of long-term
causal pathways, or of intervening events occurring after
the baseline measures. Another weakness was that cost
considerations and database limitations precluded the
inclusion of some potentially desirable indices: for
instance, Se intakes could not be calculated at baseline
because British food Se contents were not sufficiently
well established. Nevertheless, the National Diet and
Nutrition Survey series has probably included more rel-
evant biochemical and nutrient intake indices than most
population surveys except the National Health and Nutri-
tion Examination Surveys (NHANES) of North America.
In the present study, both the status indices and
the nutrient intakes which significantly predicted early
mortality appeared to be driven by basic dietary nutrient
concentrations rather than by dietary supplements. Our
conclusions from Tables 2–5, that plasma concentrations
of vitamin C, certain carotenoids and Se can be significant
Table 4. Multivariate hazard ratios for nutritional indices and intakes for all-cause mortality
(Hazard ratios and 95 % confidence intervals)
Hazard ratios (per SD) 95 % CI P Hazard ratios (per SD) 95 % CI P
Model (a): died n 717, alive n 357* Model (b): died n 482, alive n 242
Plasma Se (mmol/l) 0·76 0·69, 0·84 ,0·001 0·82 0·73, 0·91 ,0·001
Plasma Zn (mmol/l) 0·79 0·72, 0·87 ,0·001 0·84 0·76, 0·93 0·001
Plasma Cu (mmol/l) 1·27 1·14, 1·42 ,0·001 1·20 1·07, 1·34 0·002
Plasma Fe (mmol/l) 0·81 0·74, 0·89 ,0·001 0·87 0·78, 0·96 0·005
Dietary energy (MJ/d) 0·86 0·79, 0·94 0·001 0·86 0·77, 0·96 0·007
Model (c): died n 472, alive n 241 Model (d): died n 403, alive n 226
Plasma Se (mmol/l) 0·82 0·74, 0·92 0·001 0·83 0·73, 0·94 0·004
Plasma Zn (mmol/l) 0·88 0·79, 0·98 0·017 0·86 0·76, 0·97 0·017
Plasma Cu (mmol/l) 1·08 0·94, 1·22 0·3 1·02 0·88, 1·18 0·8
Plasma Fe (mmol/l) 0·87 0·78, 0·96 0·005 0·94 0·84, 1·05 0·3
Dietary energy (MJ/d) 0·87 0·77, 0·98 0·027 0·87 0·77, 0·98 0·03
* As explained in the legend to Table 1, these were the study maximum values for n (i.e. those for the dietary variables); the values for the biochemical indi-
ces were lower, see Table 1. These models, for all-cause mortality, follow on from the left-hand data column in Table 2. For the calculations in part (a),
each single (nutrient) variable was entered into the Cox proportional hazards model, together with age and sex (as in Tables 2 and 3). For those in part
(b), all of the significant (P,0·05) vitamin or mineral predictor variables from Table 3, plus age and sex, were initially included together in the model;
then those which fell below the assigned P,0·05 significance cut-off were successively removed, yielding just the significantly predictive nutrient vari-
ables in this multivariate model. For the calculations for the models in part (c), the significantly predictive vitamin or mineral indices or intakes from
model (b) were further adjusted by the inclusion of a1-antichymotrypsin (an acute-phase indicator), plasma creatinine (a renal status indicator), plasma
total and HDL-cholesterol concentrations and plasma albumin concentration. For the calculations in model (d), BMI, systolic blood pressure, current
smoking index, number of prescribed drugs being taken, self-reported health score, physical activity score and receipt (or not) of certain state benefits
(as an index of poverty) were further added to the variables in model (c).
Table 5. Multivariate hazard ratios for nutritional indices and intakes for vascular mortality*
(Hazard ratios and 95 % confidence intervals)
Hazard ratios (per SD) 95 % CI P Hazard ratios (per SD) 95 % CI P
Model (a): died n 189, alive n 337 Model (b): died n 129, alive n 242
Plasma Se (mmol/l) 0·73 0·61, 0·87 0·001 0·77 0·64, 0·94 0·01
Plasma Zn (mmol/l) 0·73 0·61, 0·88 0·001 0·77 0·63, 0·93 0·008
Plasma Cu (mmol/l) 1·35 1·12, 1·63 0·002 1·33 1·10, 1·60 0·002
Dietary energy (MJ/d) 0·83 0·70, 1·00 0·05 0·79 0·64, 0·98 0·03
Model (c): died n 125, alive n 241 Model (d): died n 105, alive n 226
Plasma Se (mmol/l) 0·81 0·66, 0·99 0·04 0·84 0·67, 1·06 0·14
Plasma Zn (mmol/l) 0·81 0·66, 1·00 0·05 0·83 0·65, 1·07 0·15
Plasma Cu (mmol/l) 1·19 0·96, 1·47 0·12 1·02 0·80, 1·30 0·9
Dietary energy (MJ/d) 0·75 0·60, 0·94 0·014 0·83 0·64, 1·07 0·16
* Please see the legend to Table 4 for an explanation of the four models, which follow on from the data, for primary vascular disease mortality, in the
right-hand data column in Table 2.
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predictors of subsequent all-cause or cardiovascular or
cancer mortality in older adults, are in agreement with
several other studies in Western countries during the past
two decades(2–14,21–24). Both plasma vitamin C and Se
also predicted mortality from primary vascular, cancer
and respiratory mortality; however, the predictive power
of individual plasma carotenoids was more variable,
between these subcategories of mortality risk. Se predic-
tion (but not that of vitamin C) persisted into six of the
eight multivariate models as shown in Tables 4 and 5,
thus appearing to be, perhaps surprisingly, robust. (The
fact that blood glutathione peroxidase, another putative
index of Se status, failed to predict mortality in any of
the models tested may be due to the fact that this
enzyme only reflects Se status in situations of relative
Se deficiency(25), and indeed, the correlation between
plasma Se and blood glutathione peroxidase was compara-
tively weak in the population studied(26).) Recent research
on Se in human nutrition has suggested a wide range of
possible interactions with disease processes, including
some important protective effects(16,27). A study based on
the Third National Health and Nutrition Examination
Survey in the USA(28) found a non-linear association
between serum Se concentration and all-cause or cancer
mortality. The range of plasma Se concentrations found
in the British National Diet and Nutrition Survey was
generally lower than that of the US study, and included
only very few (approximately 1 %) that fell into the
region of high Se concentrations that predicted shorter
survival in the US study; therefore our conclusion that
higher baseline Se concentrations are predictive of longer
survival in Britain is entirely consistent with the obser-
vations of the US study.
Plasma a-tocopherol, which was not a significant
predictor for all-cause mortality, became significant for
respiratory mortality as shown in Tables 3 and 5, and
somewhat surprisingly, vitamin E intake became significant
(only) for cancer mortality as shown in these same two
tables; carotenoid intake becoming significant (only) for
respiratory disease mortality as shown in these two
tables. The observation that plasma vitamin E differed
fundamentally from the estimated vitamin E intake in its
mortality prediction capacity seems unsurprising in view
of the relative weakness of the inter-index correlation
between these two indices (only approximately 1·6 % of
the variance of plasma a-tocopherol was explained by
the variation in vitamin E intake, based on Pearson’s corre-
lation). All of the vitamins studied plus Se (with regard
to its role at the active catalytic centre of the glutathione
peroxidase enzymes) are considered to be primarily anti-
oxidant (and hence protective) in vivo, although several
of them can also exhibit pro-oxidant (i.e. possibly deleter-
ious) properties(29–32). Dietary supplements of some
carotenoids, in particular, have been associated with an
increased risk of some degenerative diseases(33,34), and a
recent meta-analysis(35) has found consistent evidence
Table 6. Multivariate hazard ratios for nutritional indices and intakes for cancer mortality*
(Hazard ratios and 95 % confidence intervals)
Hazard ratios (per SD) 95 % CI P Hazard ratios (per SD) 95 % CI P
Model (a): died n 140, alive n 337 Model (b): died n 92, alive n 243
Plasma Se (mmol/l) 0·72 0·58, 0·89 0·002 0·79 0·63, 0·99 0·04
Plasma Zn (mmol/l) 0·69 0·55, 0·86 0·001 0·70 0·56, 0·88 0·002
Dietary vitamin E (mg/d) 0·13 0·04, 0·42 0·001 0·23 0·06, 0·84 0·026
Model (c): died n 90, alive n 242 Model (d): died n 87, alive n 227
Plasma Se (mmol/l) 0·76 0·60, 0·96 0·024 0·78 0·60, 1·01 0·06
Plasma Zn (mmol/l) 0·74 0·58, 0·95 0·019 0·74 0·57, 0·96 0·03
Dietary vitamin E (mg/d) 0·16 0·04, 0·65 0·011 0·19 0·04, 0·81 0·025
* If haem Fe is added to these models of cancer mortality, it is a significant predictor, higher values being associated with greater cancer mortality, as
follows: Model 1, 1·18 (1·03, 1·35) (0·014); Model 2, 1·15 (0·99, 1·34) (0·06); Model 3: 1·27 (1·08, 1·49) (0·003); Model 4: 1·26 (1·06, 1·50) (0·008).
Please see the legend to Table 4 for an explanation of the four models, which follow on from the data, for primary cancer mortality, in the left-hand
data column in Table 3.
Table 7. Multivariate hazard ratios for nutritional indices and intakes for respiratory disease mortality*
(Hazard ratios and 95 % confidence intervals)
Hazard ratios (per SD) 95 % CI P Hazard ratios (per SD) 95 % CI P
Model (a): died n 482, alive n 242 Model (b): died n 129, alive n 242
Plasma a-tocopherol (mmol/l) 0·76 0·60, 0·96 0·02 0·77 0·60, 0·98 0·03
Carotenoids intake (mg/d) 0·74 0·59, 0·96 0·01 0·72 0·56, 0·91 0·008
Model (c): died n 407, alive n 227 Model (d): died n 123, alive n 259
Plasma a-tocopherol (mmol/l) 0·80 0·63, 1·01 0·06 0·87 0·67, 1·14 0·3
Carotenoids intake (mg/d) 0·77 0·57, 1·04 0·09 0·86 0·62, 1·19 0·4
* Please see the legend to Table 4 for an explanation of the four models, which follow on from the data, for primary respiratory disease mortality, in the right-
hand data column in Table 3.
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for deleterious effects, on all-cause mortality, for dietary
supplements containing vitamins A, E and/or b-carotene.
Less well studied, however, is the relationship of the
mineral nutrient indices plasma Zn and Fe, as potential
predictors of future mortality. Tables 2–5 suggest that, in
the present study, these were all comparatively robust
predictors, not only of all-cause-mortality but also of two
of the three subcategories of primary mortality from vascu-
lar diseases and cancer, while plasma Zn also predicted
mortality from primary respiratory disease. Whereas Zn
is generally considered to be ‘antioxidant’ and therefore
protective in vivo (36,37), which may, in turn, be linked
to its well-established immunoprotective functions(17,38),
in redox-modulatory terms, the opposite is true for Fe,
which often exerts pro-oxidant potential. However, Fe is,
of course, an essential nutrient, and Fe deficiency is one
of the commonest recognised mineral deficiency disease
in human populations. Since in the present study, both
Zn and Fe were associated with reduced mortality risk, it
appears unlikely that their redox-modulatory properties
are dominant here. Deficiency effects (on mortality) seem
likewise unlikely, although possible. More probable,
however, is their relationship with debility and risk of mor-
tality through their relationship with chronic inflammation
and the acute-phase reaction. Both plasma Zn and plasma
Fe (or the Fe % saturation of Fe-binding transferrin)
are negative acute-phase reactants and were associated
with reduced mortality risk here. Plasma Cu, like plasma
a1-antichymotrypsin, is a positive acute-phase reactant,
and both of these indices were associated with increased
risk of all-cause and primary vascular disease mortality
(Table 2). Neither index, however, significantly predicted
primary cancer or respiratory disease mortality (Table 3),
suggesting that these two status indices may tend to
change in parallel with each other. In this context, vascular
disease is usually considered to be a long-term chronic
condition, possibly characterised by an inflammatory
state at baseline, whereas death from respiratory disease
may more often arise from acute infections near the end
of life (e.g. bronchitis, pleurisy, etc.), which might be
one of the reasons why plasma a1-antichymotrypsin and
Cu were significant predictors of vascular disease mortality
but not of respiratory disease (or cancer) mortality here.
As observed from Table 4, when a1-antichymotrypsin
was introduced as part of a suite of adjuster indices (i.e.
Table 4 part (b) v. part (a)), plasma Cu lost its significance
for the prediction for all-cause and vascular disease mor-
tality; however, this was not necessarily true for plasma
Zn or Se (Tables 4 and 5).
The pattern of significant nutrient intake predictors in
the present study seems, in some respects, to be predict-
able, but in others it is somewhat surprising. The fact
that (increased) energy intake predicted (reduced) mor-
tality in three of the models as shown in Tables 2 and 4
may simply reflect the fact that a robust appetite reflects
relatively sound health at baseline. Prediction by intakes
of vitamins C and E and carotenoids as shown in
Tables 2, 3 and 5 may reflect ‘healthy lifestyles’, including
‘healthy’ food choices, and factors such as healthy dental
status and ability to chew fruit and other rich sources of
these and related nutrients, including vitamin E and certain
minerals(39). The observed relationship between higher
haem Fe intakes and higher risk of mortality attributed to
cancer (in Table 3) seems consistent with the prevalent
view that certain categories of meat intake may represent
a risk factor for incidence of some cancers, especially
bowel cancer.
The fact that only dietary energy survived as a significant
predictor in the fully adjusted models as shown in Tables 4
and 5 may reflect the fact that many nutrient intakes
are strongly correlated with energy intakes; however, the
survival of dietary vitamin E (cancer mortality) and caroten-
oids (respiratory disease) in the absence of significance
for dietary energy may imply a special significance for
these nutrients in these diseases, and thus deserves future
investigation. It is well known that variable misreporting
of dietary intakes is a major unresolved problem for the
interpretation of all surveys that include the estimation
of nutrient intakes. Our survey sought to minimise this
problem by the use of robust 4 d diet estimates based on
weighed food intakes; furthermore, any measurement
error present would result in attenuation of the observed
relationships rather than the strengthening of relationships.
However, we acknowledge that some uncertainty remains
in this respect. In the present study, energy intake was
found to be a significant predictor of mortality when
standardised values were used, but it failed to reach
conventional significance when its values were not stan-
dardised. In contrast, the key biochemical (status) indices
all remained significant predictors of mortality, whether
or not they were standardised.
From Tables 4–7, it is clear that whereas the prediction
significance of some of the nutritional indices was progress-
ively attenuated after additional variables were included in
the multivariate models, in other instances there was a
little change, or even an increase in significance. Such vari-
ations may help to assess the relative robustness of mortality
prediction, by the different (e.g. nutrient) variables, and for
the different mortality categories.
In conclusion, a number of baseline nutrient status indi-
ces with ‘redox-modulatory’ connotations appear to predict
all-cause, primary vascular disease, cancer or respiratory
disease mortality in older British adults. Of these, plasma
Se, Zn and Fe appeared to be especially robust, with
plasma vitamins C, E and carotenoids being predictive in
some, but not all, of the models examined. Some of the
status indices (especially plasma Cu) appeared to reflect
acute-phase status; others (including dietary intakes of
certain nutrients) may have reflected the robustness of
appetites and dentition, and ‘healthiness’ of lifestyles (see
Khaw et al.(40)). Future studies should attempt to deter-
mine, first, which nutrients are the most frequent predictors
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of all-cause and specific-cause mortality in different popu-
lations, and second, whether these predictions can imply
causal relationships, such that dietary or other interven-
tions might promote disease-free longevity.
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